Information Journal Paper
APA:
CopyRAYBURN, E.. (2005). MDM2 AND HUMAN MALIGNANCIES: EXPRESSION, CLINICAL PATHOLOGY, PROGNOSTIC MARKERS AND IMPLICATION FOR CHEMOTHERAPY. CURRENT CANCER DRUG TARGETS, 5(1), 27-41. SID. https://sid.ir/paper/558261/en
Vancouver:
CopyRAYBURN E.. MDM2 AND HUMAN MALIGNANCIES: EXPRESSION, CLINICAL PATHOLOGY, PROGNOSTIC MARKERS AND IMPLICATION FOR CHEMOTHERAPY. CURRENT CANCER DRUG TARGETS[Internet]. 2005;5(1):27-41. Available from: https://sid.ir/paper/558261/en
IEEE:
CopyE. RAYBURN, “MDM2 AND HUMAN MALIGNANCIES: EXPRESSION, CLINICAL PATHOLOGY, PROGNOSTIC MARKERS AND IMPLICATION FOR CHEMOTHERAPY,” CURRENT CANCER DRUG TARGETS, vol. 5, no. 1, pp. 27–41, 2005, [Online]. Available: https://sid.ir/paper/558261/en